All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


The Application Value of Interleukin-10 and Interleukin-15 in Osteoporosis

DOI: 10.4236/oalib.1107279, PP. 1-6

Subject Areas: Nursing, Orthopedics

Keywords: Osteoporosis, Interleukin 10, Interleukin 15, Bone loss

Full-Text   Cite this paper   Add to My Lib


Objective: To investigate the effects of cytokines IL-10 and IL-15 in osteoporosis, and to provide a basis for the prevention and treatment of osteoporosis. Methods: A total of 101 subjects who underwent bone density testing in Linyi People’s Hospital from January 2018-December 2019 were selected and divided into normal bone density group, osteopenia group and osteoporosis group according to their bone density. At the same time, the peripheral serum IL-10 and IL-15 levels of subjects were detected. Results: The serum IL-10 and IL-15 levels of subjects with normal bone density were significantly higher than those of subjects with bone loss (t = 5.31, P < 0.001) (t = 6.87, P < 0.001) and osteoporosis. In the subjects (t = 5.38, P < 0.001) (t = 5.30, P < 0.001), the bone mineral density of the lumbar spine L1-L4 was positively correlated with serum IL-15 levels (r = 0.216, P = 0.030), but with IL-10 No correlation (r = ?0.025, P = 0.801). Femoral neck bone mineral density was positively correlated with serum IL-10 levels (r = 0.209, P = 0.036), and femoral neck bone mineral density was positively correlated with serum IL-15 levels (r = 0.405, P < 0.001). Stepwise regression analysis shows that IL-15 is closely related to bone density. Conclusion: Serum IL-10 and IL-15 have a protective effect on bone mass. Two anti-inflammatory cytokines play an important role in the occurrence and development of osteoporosis. Low levels of serum IL-10 and IL-15 have a protective effect on bone mass. Bone loss and osteoporosis have certain evaluation value, which can be used to prevent the occurrence of osteoporosis, reduce the risk of fracture, and reduce the difficulty and burden of nursing.

Cite this paper

Lei, T. , Wang, M. , Zuo, C. and Xu, H. (2021). The Application Value of Interleukin-10 and Interleukin-15 in Osteoporosis. Open Access Library Journal, 8, e7279. doi:


[1]  Tosi, L.L. and Lane, J.M. (1998) Osteoporosis Prevention and the Orthopaedic Surgeon: When Fracture Care Is Not Enough. The Journal of Bone and Joint Surgery, 80, 1567-1569.
[2]  王三杏, 谢雍, 董矜, 等. 成人骨密度与慢性炎症的相关性分析[J]. 标记免疫分析与临床, 2016, 23(7): 717-721.
[3]  李伟, 罗南萍, 孙晓明, 等. IL-6、TNF-α在老年骨质疏松症中的临床价值探讨[J]. 放射免疫学杂志, 2008, 21(2): 106-108.
[4]  蒲嘉骐, 郝杰. 特殊人群骨质疏松症研究进展[J]. 中国骨质疏松杂志, 2015, 21(6): 100-104.
[5]  Tural, S., Alayli, G., Kara, N., et al. (2013) Association between Osteoporosis and Polymorphisms of the IL-10 and TGF-Beta Genes in Turkish Postmenopausal Women. Human Immunology, 74, 1179-1183.
[6]  Perera, P.Y., Lichy, J.H., Waldmann, T.A., et al. (2012) The Role of Interleukin-15 in Inflammation and Immune Responses to Infection: Implications for Its Therapeutic Use. Microbes & Infection, 14, 247-261.
[7]  杨鸿兵, 郭美灵, 何旭颖, 等. 63例QCT腰椎骨骨密度测量与DTX-200双能X前臂骨骨密度测量对比分析[J]. 中国骨质疏松杂志, 2011, 17(3): 38-41.
[8]  Ginaldi, L., Benedetto, M.C.D. and Martinis, M.D. (2005) Osteoporosis, Inflammation and Ageing. Immunity & Ageing, 2, Article No. 14.
[9]  夏婷, 李双庆. 炎症相关骨质疏松症的发病机制[J]. 中国骨质疏松杂志, 2015, 21(1): 117-120.
[10]  杜艳萍, 程群. 炎症在骨质疏松发生中的作用与机制研究新进展[J]. 老年医学与保健, 2013, 19(6): 427-431.
[11]  Strle, K., Mccusker, R.H., Tran, L., et al. (2007) Novel Activity of an Anti-Inflammatory Cytokine. Journal of Neuroimmunology, 188, 48-55.
[12]  胡道军, 罗欣, 黄海良, 等. IL-10抑制脂多糖诱导的Hela细胞IL-15和IL-6转录[J]. 中国生化药物杂志, 2010, 31(2): 85-89.
[13]  Zhang, Q., Chen, B., Yan, F., et al. (2014) Interleukin-10 Inhibits Bone Resorption: A Potential Therapeutic Strategy in Periodontitis and Other Bone Loss Diseases. BioMed Research International, 2014, Article ID: 284836.
[14]  Ishimitsu, R., Nishimura, H., Yajima, T., et al. (2001) Overexpression of IL-15 in Vivo Enhances Tc1 Response, Which Inhibits Allergic Inflammation in a Murine Model of Asthma. Journal of Immunology, 166, 1991-2001.
[15]  O’Leary, M.F., Wallace, G.R., Bennett, A.J., et al. (2017) IL-15 Promotes Human Myogenesis and Mitigates the Detrimental Effects of TNFα on Myotube Development. Scientific Reports, 7, Article No. 12997.
[16]  小尾, 佳嗣, 濱野, 高行. CKDとビタミンD欠乏(第15回日本骨粗鬆症学会 シンポジウム6 CKD患者の骨) [J]. オステオポローシスジャパン: 日本骨粗鬆症学会雑誌, 2014, 22: 34-38.
[17]  马永成, 郝永强. 肌肉与骨质疏松症[J]. 国际骨科学杂志, 2006, 27(6): 334-336.
[18]  王建华, 冯玫, 许佳佳, 等. 骨骼肌质量与骨含量的相关性研究[J]. 中国药物与临床, 2019, 19(6): 960-961.
[19]  Kiel, D. (1995) National Osteoporosis Foundation Working Group in Vertebral Fractures. Journal of Bone and Mineral Research, 10, 518-523.


comments powered by Disqus

Contact Us


微信:OALib Journal